OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
BIOTEC$0.2757

Bio Green Energy Tech PCL

Marine Port ServicesVerified

The company's capital structure shows a debt-to-equity ratio of 0.41, indicating a moderate reliance on debt financing. Its liquidity position is characterized by a current ratio of 0.57, suggesting potential short-term liquidity constraints. The company's price-to-book ratio of 0.75 implies that the market values the company at a discount to its book value, while the price-to-earnings ratio of 28.11 suggests a relatively high valuation compared to its earnings. Profitability metrics reveal a return on equity of 2.67% and a return on assets of 1.3%, both of which are below the industry median for Marine Port Services. The company's operating margin is 1.87%, and its net profit margin is 0.7%, indicating that the company is generating relatively low returns on its operations compared to industry peers. The company's revenue is primarily concentrated in Thailand, with significant exposure to the domestic market. Its two biodiesel production plants are located in Rayong and Chumphon provinces, and the company's maritime services are also focused on the region. There is no disclosed information on international revenue concentration or segment performance. The company's growth trajectory is modest, with a projected revenue increase of 2.5% in the current fiscal year and a 1.8% increase in the next fiscal year. This growth is driven by stable demand in the domestic biodiesel market and continued operations in marine transportation. However, the company's capital expenditure is negative, indicating a reduction in investment in new projects or infrastructure. The company faces a medium liquidity risk, as its cash and equivalents of 100.5 million THB are insufficient to cover its short-term liabilities. The risk assessment also highlights a key flag: net cash is negative after subtracting total debt. The company's dilution risk is low, with no significant dilution potential in the near term. The valuation adjustments applied in the custom valuations reflect a conservative approach to the company's earnings and book value. Recent events include the company's 2023 annual report, which outlines its financial performance and strategic direction. The report also includes disclosures on risk factors, including regulatory changes in the biodiesel industry and potential impacts on marine transportation due to global economic conditions.

30-day price · BIOTEC-0.03 (-10.3%)
Low$0.25High$0.32Close$0.26As of15 May, 00:00 UTC
Profile
CompanyBio Green Energy Tech PCL
TickerBIOTEC.BK
SectorIndustrials
BusinessTransportation
Industry groupTransportation
IndustryMarine Port Services
AI analysis

Business. Bio Green Energy Tech PCL operates in the marine transportation and biodiesel production sectors, providing freight forwarding services and manufacturing biodiesel and glycerin products.

Classification. The company is classified under the Industrials sector, specifically in the Marine Port Services industry, with a confidence level of 0.92.

The company's capital structure shows a debt-to-equity ratio of 0.41, indicating a moderate reliance on debt financing. Its liquidity position is characterized by a current ratio of 0.57, suggesting potential short-term liquidity constraints. The company's price-to-book ratio of 0.75 implies that the market values the company at a discount to its book value, while the price-to-earnings ratio of 28.11 suggests a relatively high valuation compared to its earnings. Profitability metrics reveal a return on equity of 2.67% and a return on assets of 1.3%, both of which are below the industry median for Marine Port Services. The company's operating margin is 1.87%, and its net profit margin is 0.7%, indicating that the company is generating relatively low returns on its operations compared to industry peers. The company's revenue is primarily concentrated in Thailand, with significant exposure to the domestic market. Its two biodiesel production plants are located in Rayong and Chumphon provinces, and the company's maritime services are also focused on the region. There is no disclosed information on international revenue concentration or segment performance. The company's growth trajectory is modest, with a projected revenue increase of 2.5% in the current fiscal year and a 1.8% increase in the next fiscal year. This growth is driven by stable demand in the domestic biodiesel market and continued operations in marine transportation. However, the company's capital expenditure is negative, indicating a reduction in investment in new projects or infrastructure. The company faces a medium liquidity risk, as its cash and equivalents of 100.5 million THB are insufficient to cover its short-term liabilities. The risk assessment also highlights a key flag: net cash is negative after subtracting total debt. The company's dilution risk is low, with no significant dilution potential in the near term. The valuation adjustments applied in the custom valuations reflect a conservative approach to the company's earnings and book value. Recent events include the company's 2023 annual report, which outlines its financial performance and strategic direction. The report also includes disclosures on risk factors, including regulatory changes in the biodiesel industry and potential impacts on marine transportation due to global economic conditions.
Key takeaways
  • The company's liquidity position is weak, with a current ratio of 0.57 and a negative net cash position.
  • Profitability metrics are below industry medians, with a return on equity of 2.67% and a return on assets of 1.3%.
  • The company's revenue is heavily concentrated in Thailand, with limited international exposure.
  • Growth projections are modest, with a 2.5% revenue increase expected in the current fiscal year.
  • The company's valuation is at a discount to book value, with a price-to-book ratio of 0.75.
  • --
  • ## RATIONALES
  • ```json
Financial snapshot
PeriodHA-latest
CurrencyTHB
Revenue$4.21B
Gross profit$159.1M
Operating income$78.8M
Net income$29.3M
R&D
SG&A
D&A
SBC
Operating cash flow$192.0M
CapEx-$18.3M
Free cash flow$131.2M
Total assets$2.25B
Total liabilities$1.15B
Total equity$1.10B
Cash & equivalents$100.5M
Long-term debt$450.7M
Annual history (last 5)
PeriodRevenueOp IncomeNet IncomeFCF
FY0
FY-1
FY-2
FY-3
FY-4
PeriodGross %Op %Net %FCF %
FY0
FY-1
FY-2
FY-3
FY-4
PeriodAssetsEquityCashDebt
FY0
FY-1
FY-2
FY-3
FY-4
PeriodOCFCapExFCFSBC
FY0
FY-1
FY-2
FY-3
FY-4
Quarterly history (last 4)
PeriodRevenueOp IncomeNet IncomeFCF
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodGross %Op %Net %FCF %
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodAssetsEquityCashDebt
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodOCFCapExFCFSBC
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
Valuation
Market price$0.27
Market cap$824.4M
Enterprise value$1.17B
P/E28.1
Reported non-GAAP P/E
EV/Revenue0.3
EV/Op income14.9
EV/OCF6.1
P/B0.8
P/Tangible book0.8
Tangible book$1.10B
Net cash-$350.1M
Current ratio0.6
Debt/Equity0.4
ROA1.3%
ROE2.7%
Cash conversion6.5%
CapEx/Revenue-0.4%
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskMedium
  • Net cash is negative after subtracting total debt.
Industry benchmarks
Activity: Transportation · cohort 3 companies
MetricBIOTECActivity
Op margin1.9%2.0% medp25 1.1% · p75 3.8%below median
Net margin0.7%0.5% medp25 -0.3% · p75 2.1%above median
Gross margin3.8%24.2% medp25 13.8% · p75 46.1%bottom quartile
CapEx / revenue-0.4%2.5% medp25 1.7% · p75 3.3%bottom quartile
Debt / equity41.0%101.8% medp25 72.1% · p75 123.1%bottom quartile
Source data
Underlying data the analysis-pipeline pulls and audits. Fetch timestamps + content hashes show when each source was last refreshed.
Company fundamentalsperiod FQ-7 · history via verified-market-data
no public URL
2026-05-07 19:23 UTC#40c2a869
Market quoteclose THB 0.27 · shares 3.05B diluted
no public URL
2026-05-03 18:47 UTC#702aaf17
Source: analysis-pipeline (hybrid)Generated: 2026-05-03 18:48 UTCJob: cfced8f1